Cosentyx snrdy 300MG dose-2PENML
Ended Awarded
- Contract number
- SPE2DB26FXCS2
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,874
Award facts
- Contract value 100% obligated
- $7,874.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Cosentyx (secukinumab) 300mg dose in 2-pen/ml format, with a contract ceiling value of $7,874.20 and an ultimate completion date of October 24, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.9 billion vehicle running through December 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
Cosentyx is a biologic immunosuppressant used to treat various inflammatory and autoimmune conditions, making this delivery order part of the company's broader role as a critical pharmaceutical supplier to the Defense Health Agency and other federal military healthcare systems. AmerisourceBergen's DLA prime vendor contract facilitates the supply of specialty medications, brand-name and generic drugs, vaccines, and related medical supplies to support military healthcare programs globally. The agency is planning to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, reflecting the strategic importance of reliable pharmaceutical supply chains for military medical operations.
Quick answers
Who was awarded contract SPE2DB26FXCS2?
SPE2DB26FXCS2 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 23, 2025.
How much is contract SPE2DB26FXCS2 worth?
The government has obligated $7,874 on SPE2DB26FXCS2.
Is contract SPE2DB26FXCS2 an order under another contract?
Yes. SPE2DB26FXCS2 is a delivery order under SPE2DB24D2003, an indefinite delivery contract.
Was contract SPE2DB26FXCS2 competed?
The extent of competition for SPE2DB26FXCS2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award